A Cochrane review found that the effects of screening are uncertain in terms of chlamydia transmission but that screening probably reduces the risk of pelvic inflammatory disease in women.In the United Kingdom the National Health Service (NHS) aims to:

Prevent and control chlamydia infection through early detection and treatment of asymptomatic infection;
Reduce onward transmission to sexual partners;
Prevent the consequences of untreated infection;
Test at least 25 percent of the sexually active under 25 population annually. Retest after treatment. Treatment
C. trachomatis infection can be effectively cured with antibiotics. Guidelines recommend azithromycin, doxycycline, erythromycin, levofloxacin or ofloxacin. In men, doxycycline (100 mg twice a day for 7 days) is probably more effective than azithromycin (1 g single dose) but evidence for the relative effectiveness of antibiotics in women is very uncertain. Agents recommended during pregnancy include erythromycin or amoxicillin.An option for treating sexual partners of those with chlamydia or gonorrhea includes patient-delivered partner therapy (PDT or PDPT), which is the practice of treating the sex partners of index cases by providing prescriptions or medications to the patient to take to his/her partner without the health care provider first examining the partner.Following treatment people should be tested again after three months to check for reinfection. Epidemiology
Globally, as of 2015, sexually transmitted chlamydia affects approximately 61 million people. It is more common in women (3.8%) than men (2.5%). In 2015 it resulted in about 200 deaths.In the United States about 1.6 million cases were reported in 2016.
"The ancestral shape hypothesis: An evolutionary explanation for the occurrence of intervertebral disc herniation in humans". BMC Evolutionary Biology. 15: 68. doi:10.1186/s12862-015-0336-y. PMC 4410577. PMID 25927934. McFadden, K D; Taylor, J R (1989). "End-Plate Lesions of the Lumbar Spine". Spine. 14 (8): 867–9. doi:10.1097/00007632-198908000-00017. PMID 2781398. S2CID 38418323. Peng, B.; Wu, W.; Hou, S.; Shang, W.; Wang, X.; Yang, Y. (August 2003). "The pathogenesis of Schmorls nodes". The Journal of Bone and Joint Surgery. British Volume. 85-B (6): 879–882. doi:10.1302/0301-620X.85B6.13555. PMID 12931811. Takahashi, K.; Miyazaki, T.; Ohnari, H.; Takino, T.; Tomita, K. (1995). "Schmorls nodes and low-back pain". European Spine Journal. 4 (1): 56–9. doi:10.1007/bf00298420. PMID 7749909. S2CID 26284846. Sherrell, Zia (19 May 2022). "Schmorl nodes: Symptoms, causes, and treatment". Medical News Today. Kim, Hyeun Sung; Raorane, Harshavardhan Dilip; Sharma, Sagar Bhupendra; Wu, Pang Hung; Jang, Il-Tae (December 2020). "Infected Schmorls node: a case report". BMC Musculoskeletal Disorders. 21 (1): 280. doi:10.1186/s12891-020-03276-4. PMC 7196219. PMID 32359347. == External links ==